EMEA-002274-PIP01-17

Key facts

Active substance
trandolapril
Therapeutic area
Cardiovascular diseases
Decision number
P/0192/2018
PIP number
EMEA-002274-PIP01-17
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Abbott Laboratories Limited

Tel.  +44 (0) 1628 644513
E-mail: robyn.hall@abbott.com

Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating